Galvanize Therapeutics, Inc.
Steven Anheier has extensive work experience in finance and accounting roles. Steven is currently serving as the Chief Financial Officer at Galvanize Therapeutics, Inc. starting from November 2022. Before that, they worked at Vocera Communications as the Chief Financial Officer from June 2021 to May 2022 and as the Vice President - Finance & Accounting from September 2019 to June 2021. Prior to that, Steven worked at Accuray in various roles including Vice President Finance & Investor Relations from September 2018 to August 2019, Vice President - Finance (FP&A) from September 2017 to August 2018, Senior Director of Finance (FP&A) from October 2015 to August 2017, Director of FP&A from June 2014 to September 2015, and Analyst, Manager, Sr. Manager from March 2010 to May 2014. Steven started their career as a Senior Audit Associate at KPMG Peat Marwick from September 2006 to February 2010.
From 2002 to 2006, Steven Anheier attended California Polytechnic State University-San Luis Obispo. During their time there, they focused on studying accounting, however, the information does not specify whether they obtained a degree in this field.
This person is not in any offices
Galvanize Therapeutics, Inc.
1 followers
Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitissymptoms, cardiac arrhythmias, and solid tumors.It was formed by Apple Tree Partners in 2022.